Phibro Animal Health (PAHC) EBITDA Margin (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly EBITDA Margin of 11.64% for Q1 2026, up 201.0% year-over-year from 3.87% in Q1 2025, and down 13.5% quarter-over-quarter from 13.46% in Q4 2025.
Phibro Animal Health (PAHC) EBITDA Margin (2012 - 2026) Analysis & Trends
Phibro Animal Health's EBITDA Margin history runs 15 years deep, the most recent figure standing at 11.64% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 201.0% year-over-year to 11.64%; the TTM figure through Mar 2026 stood at 12.0% (up 400.0% YoY), while the FY2025 annual figure was 8.52%, up 328.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 11.64%, down from 13.46% in the prior quarter.
- The five-year high for EBITDA Margin was 14.09% in Q3 2025, with the low at 0.31% in Q3 2023.
- The 5-year median for EBITDA Margin is 8.01% (2022), against an average of 8.19%.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin plunged 620 bps in 2023, then jumped 729 bps in 2025.
- Phibro Animal Health's EBITDA Margin stood at 6.48% in 2022, then dropped by 3 bps to 6.28% in 2023, then surged by 31 bps to 8.26% in 2024, then surged by 63 bps to 13.46% in 2025, then declined by 14 bps to 11.64% in 2026.
- Business Quant data shows PAHC's EBITDA Margin at 11.64% in Q1 2026, 13.46% in Q4 2025, and 14.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 11.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.64% |
| Dec 31, 2025 | 13.46% |
| Sep 30, 2025 | 14.09% |
| Jun 30, 2025 | 8.90% |
| Mar 31, 2025 | 9.64% |
| Dec 31, 2024 | 8.26% |
| Sep 30, 2024 | 6.80% |
| Jun 30, 2024 | 6.74% |
| Mar 31, 2024 | 7.57% |
| Dec 31, 2023 | 6.28% |
| Sep 30, 2023 | -0.31% |
| Jun 30, 2023 | 9.32% |
| Mar 31, 2023 | 7.55% |
| Dec 31, 2022 | 6.48% |
| Sep 30, 2022 | 5.89% |
| Jun 30, 2022 | 8.97% |
| Mar 31, 2022 | 8.01% |
| Dec 31, 2021 | 9.58% |
| Sep 30, 2021 | 6.81% |
| Jun 30, 2021 | 8.70% |